DESMOND... Where you at?

[PatientlyWaiting]

I wouldnt worry, theyre not photoshopped images like some other HT doctors are known to do. Its a legitimate clinical trial.

With the horrible quality and all and looking like Babe Ruth era photography, they still show obvious regrowth on slick bald scalp. That is enough for me.

[hellouser]

Any idea why they would use these kinds of photos instead of ones that clearly show the subjects?

Nope.

Or were the photos possibly altered before being made public?

I don't think Dr. Nigam's team worked on these.

[MrBlonde]

What are the side effects of BNP-32?

[MrBlonde]

Hey guys

I've got another MIND BLOWING news for you guys! Up until now, we have been unable to multiply Dermal Papillae cells to sufficient numbers without them losing their trichogenicity (hair inducing potential)!

Now, don't forget this is where Tsuji lab was stuck on! Once we can multiply DP cells, Tsuji lab is ready to go!

It's the most promising discovery for the hairloss community!

Awesome news Des. Again this leads back to the golden question. How long from breakthrough to Market?

[hellouser]

What are the side effects of BNP-32?

Nesiritide's side effects are:

• dizziness, chest pain, fast heart rate, or confusion shortly after you receive nesiritide;
• feeling light-headed, fainting;
• coughing up blood; or
• fever, pale skin, easy bruising, unusual weakness.

Less serious side effects may include:

• pain, itching, or swelling where the IV needle was...

Link:
http://www.rxlist.com/natrecor-drug.htm

Nesiritide (Natrecor) is the recombinant form of the 32 amino acid human B-type natriuretic peptide, which is normally produced by the ventricular myocardium. Nesiritide works to facilitate cardiovascular fluid homeostasis through counterregulation of the renin-angiotensin-aldoesterone system, stimulating cyclic guanosine monophosphate, leading to smooth muscle cell relaxation.

Neseritide was believed initially to be beneficial for acute decompensated congestive heart failure. It received FDA approval for this purpose in 2001 after initial non-approval. In July 2011 the results of the largest study so far for nesiritide was published in The New England Journal of Medicine (NEJM); it showed that nesiritide was not associated with a change in mortality or re-hospitalizations.

As for the trial itself with BNP-32 injected into the scalp, the side effects were: '[0673] Moreover, BNP and CNP did not exhibit any adverse events such as local symptoms of irritation, skin atrophy, or an itching sensation resulting from their application, and there were no systemic side effects. '

Here's the study:
http://www.faqs.org/patents/app/20120238498